BridgeMD
New treatment option for Uncontrolled Arterial Hypertension
Official title Prediction of Blood Pressure Outcomes Following Renal Denervation (PREDICT-RDN)
ClinicalTrials.gov ID: NCT06845579
What this study is testing
- What it's testing
- Prospective, single arm trial to assess the effects of renal denervation on day-by-day blood pressure measurements and time in blood pressure target range, as well as establish a multivariate prediction model for blood pressure reduction after renal denervation.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Confirmed arterial hypertension with systolic or diastolic blood pressure \>140/90 mmHg in standardized office blood pressure measurement
- Treatment with 3 to ≤5 antihypertensive drug classes
- Age \>18 years
- Written informed consent
You likely can't join if
- Age ≤ 18 years
- anatomy unsuitable for renal denervation (i.e. renal artery stenosis, single functioning kidney)
- pregnancy
- patients under legal supervision or guardianship
- participation in other trials that might interfere with the study outcome according to the opinion of one of the investigators.
The study team makes the final eligibility decision.
Where it's taking place
- Mainz, Rheinland Pflanz, Germany
- Leipzig, Saxony, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Mainz, Rheinland Pflanz, Germany; Leipzig, Saxony, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.